We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Collection of documents relating to COVID-19 treatments.
These documents explain the alternative remedies package (ARP) and how eligible bodies can participate.
Patients with severe alopecia areata (patchy hair loss) could access a new medicine to help treat their condition.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Batches of Legency Remedies Pvt Ltd irrigation, inhalation and eye wash saline products manufactured between April and November 2023 are being recalled due to potential microbiological contamination.
This page provides links to guidance produced by, or relating to, the Insolvency Service
Product Safety Report for Anise Shealight Fading Cream Face & Body (Batch AOS18, 18/06/2023) presenting a serious chemical risk.
Case studies from across the health and social care sector showing examples of good practice in preventing health problems from happening.
We want to remind healthcare professionals that use of systemic (oral and injectable) NSAIDs such as ibuprofen, naproxen, and diclofenac is contraindicated in the last trimester of pregnancy (after 28 weeks of pregnancy).
Guidance on merger remedies in Phase 1 and Phase 2 investigations.
Which chemicals you can use in or near a bat roost and what you need to know before you use them.
Statistics relating to estimates of the cost of tax reliefs.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (29 January 2024) approved the medicine Rezzayo (rezafungin) to treat a fungal infection called invasive candidiasis.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).